quitting7oh.org

MAT / Suboxone

Why Suboxone Might Not Be Working — Read This First

Why bupe sometimes doesn't cover you — SNRI symptoms, the dose-ceiling question, long-acting compounds.

If you’re freaking out because bupe isn’t doing what you thought it would: you’re not broken, your medication isn’t broken, and you’re not failing. There are real, well-understood reasons it can feel inadequate, especially coming off 7-OH and related compounds. Standard Suboxone protocols were built around heroin, oxy, and prescription opioids. What we’re recovering from is genuinely different in several ways, and the medication needs to be used a little differently to fully cover what’s happening.

This community leans toward short-term tapers, so most of what’s below is about how to make bupe work well enough to get you through to the other side, not about long-term maintenance.

The big one: bupe doesn’t touch the SNRI side of withdrawal

This is the part most people aren’t told, and it’s the single biggest reason Suboxone feels incomplete for our population.

7-OH and the related synthetics are not pure opioids. The minor alkaloids in concentrated kratom and synthetic products, including rhynchophylline, corynantheidine, mitraphylline, and others, produce SNRI-like effects on top of the mu-opioid action. They modulate norepinephrine and serotonin, which means the dependence you’ve built isn’t just to an opioid, it’s to a compound that’s been functioning as a partial opioid + a partial antidepressant + a partial anxiolytic, all rolled into one.

When you stop, you don’t just get opioid withdrawal. You get opioid withdrawal plus a noradrenergic crash plus a serotonergic crash, all at the same time. That’s a different physiological event than what classical opioid recovery resources describe.

Suboxone is purely opioid-receptor medication. It does an excellent job covering the opioid side. It does nothing for the SNRI side. So the symptoms that come from the SNRI withdrawal don’t go away just because you started bupe. Specifically:

  • Wired anxiety. Not the calm-but-uneasy kind, the can’t-sit-still, jumping-out-of-skin kind.
  • Insomnia that doesn’t respond to feeling tired. Your body is exhausted, your brain is wide awake.
  • Brain zaps. That electric, jolting sensation in your head, sometimes with movement. Classic SNRI discontinuation symptom.
  • Restless legs and arms, especially at night.
  • Crying jags or emotional lability. Sudden tears or irritability with no clear trigger.
  • Sensory hypersensitivity. Lights too bright, sounds too loud, skin too sensitive.
  • Sweating, especially at night, even when bupe is otherwise covering you.
  • A specific “off” feeling that you can tell is different from opioid withdrawal but you can’t quite name.

If any of this sounds like what you’re experiencing on bupe, bupe is doing its job and there’s a separate piece that needs separate help. The fix is not more bupe. The fix is adjuncts.

Adjuncts that actually help with the SNRI piece - Provider attitudes vary; see #quickmd-info for telehealth options.

  • Clonidine. Alpha-2 agonist. Takes the edge off the noradrenergic symptoms (sweating, anxiety, fast heart rate, restlessness). Most prescribers familiar with MAT will prescribe this on request.
  • Hydroxyzine. Non-addictive antihistamine that helps with anxiety and sleep without controlled-substance risk. Easy to get prescribed. Caveat: hydroxyzine is a first-generation antihistamine (H1 antagonist), and antihistamines have been associated with worsening restless legs syndrome and may exacerbate other withdrawal symptoms in some people. If you’re already struggling with RLS, twitchy legs, or jumpy/agitated symptoms, hydroxyzine may make these worse rather than better. Worth trying carefully, but if you notice your legs getting worse after starting it, that’s a known mechanism and a reason to switch to a different adjunct.
  • Gabapentin. Anxiety, restless legs, sleep, brain zaps. Genuinely effective.
  • Trazodone. Sleep specifically, especially the broken/restless sleep that hits hard with SNRI withdrawal.
  • Baclofen. Muscle relaxant; helps with the body tension and aches that are partly opioid and partly noradrenergic.
  • Magnesium glycinate. OTC. Genuinely helps with the restless-legs, muscle-tension, anxiety cluster.
  • L-theanine. OTC. Takes the edge off without sedation.

See #vitamins-supplements for the full picture on supplement support.

Dose: you might just need more

This is the second-biggest thing people don’t get told. The “right” dose of bupe varies a lot between people, and landing at too low a dose is one of the most common reasons bupe feels inadequate.

This community uses a low-and-slow induction (start at 2 mg, titrate up by 1 mg as needed) precisely because we don’t want people parked at a higher dose than they need. But the flip side is also true: if you’re parked too low, the bupe isn’t covering you, and that’s a fixable problem.

If you’re at 2 mg and you’re still feeling withdrawal symptoms throughout the day, your dose is probably too low. If you’re at 4 mg and feeling waves of return-of-symptoms before your next dose, your dose is probably too low. Most people coming off 7-OH land somewhere in the 4 to 8 mg range when fully covered. Some need less, some need more.

On the dose ceiling: the conventional wisdom held that buprenorphine has a flat ceiling at 24 to 32 mg/day, meaning higher doses don’t add benefit. More recent research has challenged this, suggesting the ceiling effect is more individual than the older guidance assumed and some patients do get meaningful benefit at higher doses. This community doesn’t generally encourage going above 8 mg/day because higher doses make tapering harder and longer, and most 7-OH users don’t need it. But if your prescriber suggests a higher dose because you’re not stabilizing, the newer research supports that being a reasonable approach.

The practical takeaway: if you’re struggling on bupe, before assuming the medication isn’t working, check whether you’re at a dose that covers you. Track when symptoms return relative to dosing. If they’re returning hours before your next dose, talk to your prescriber about either a higher dose or splitting your daily dose into two smaller doses (morning and evening) to keep blood levels more stable.

If you’ve been on long-acting synthetics or stacked compounds

Most people in this community are coming off 7-OH, but if you’ve also been on MGM-15, MIT-A, or pseudo, the picture changes meaningfully:

MGM-15 is a dual mu/delta receptor agonist. Buprenorphine is essentially mu-only and is actually a delta antagonist. The delta contribution to mood, analgesia, and overall opioid tone gets removed entirely when you switch off MGM-15. This shows up as restlessness, anhedonia, low mood, and a persistent low-grade “off” feeling that lasts longer than 7-OH users typically experience. It’s not in your head, it’s pharmacology. See #mgm-15 for the full breakdown.

Pseudo (mitragynine pseudoindoxyl) binds the mu receptor tighter than buprenorphine itself does. Even when bupe is on board, displacement and stabilization can be incomplete in a way that doesn’t happen with 7-OH.

MIT-A/DHM is long-acting and the literature is thin. Treat it like MGM-15 in terms of needing more time and potentially higher stabilization doses.

If any of these were in the mix, be honest with your prescriber about what you’ve actually used. Most providers haven’t heard of these compounds, and if they’re running the standard kratom playbook on someone who’s actually been on a long-acting full mu/delta agonist, of course bupe isn’t going to feel right.

There’s also a partial agonist ceiling effect that matters here: bupe activates mu receptors less than full agonists do. Coming off MGM-15 or pseudo, you’re stepping receptor activation down rather than replacing it 1:1. For 7-OH this gap is usually manageable; for the heavier synthetics it’s significant.

What to do right now if Suboxone isn’t working

  1. Check the SNRI piece first. If you have any of the symptoms in the SNRI list above, that’s where the problem is. Get clonidine, hydroxyzine, gabapentin, or trazodone added.
  2. Check your dose. Are you genuinely covered, or parked too low? If symptoms return before your next dose, your dose is too low or you need to split it.
  3. Be honest about what you were on. If MGM-15, MIT-A, or pseudo were in the mix, the playbook changes.
  4. Don’t bail in the first 1-2 days. This is when most people quit, because it’s when bupe feels least like what their body was used to and the SNRI symptoms are at their worst. Your dose may not be dialed in yet, your adjuncts may not be in your system yet. Push through to day 2 or 3 with the right dose and adjuncts in place.
  5. Don’t redose your old compound to take the edge off. That’s how this restarts.
  6. Talk to the community. People in our Discord and subreddit have lived through what you’re going through with these specific compounds.

When to seek emergency help

  • Severe symptoms that won’t resolve and feel unmanageable
  • Any thoughts of self-harm or suicide. Call or text 911.
  • Inability to keep down fluids for more than 24 hours
  • Severe chest pain or irregular heartbeat
  • Mental health crisis

None of those is giving up. They’re tools.

A note on patience

The standard recovery resources tell you bupe will make you feel “back to normal” pretty quickly. For our population, that’s not always true on the standard timeline. The first few days are the hardest, and day 1 to 2 is when most people in this community quit. That’s exactly the window where bupe hasn’t fully kicked in, your dose probably isn’t optimized yet, and the SNRI symptoms haven’t responded to adjuncts that need a day or two to take effect. Push through. Adjuncts help. The right dose helps. By day 4 or 5 most people are in noticeably better shape than day 1 or 2.

If you’re approaching the end of your taper and still feel terrible, that’s worth its own conversation in #suboxone. There may be something specific to your situation worth troubleshooting.

Sources

Last updated: Edit this page on GitHub